Revelation Biosciences Inc expected to post a loss of $6.88 a share - Earnings Preview
06/05/2025 12:15
Revelation Biosciences Inc REVB.OQ REVB.O is expected to show no change in quarterly revenue when it reports results on May 8 (estimated) for the period ending March 31 2025 LSEG's mean analyst estimate for Revelation Biosciences Inc is for a loss of $6.88 per share. The one available analyst rating on the shares is "buy". The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Revelation Biosciences Inc is $170.73, above its last closing price of $2.90. This summary was machine generated May 6 at 11:15 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)